Jonathan Silverstein, Director, 10% Owner at Arcutis Biotherapeutics, Inc. (ARQT), bought 496,000 shares at $25.00 ($12.4M) on 2020-10-02, disclosed to the SEC on 2020-10-06.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $25.00 | 200,000 | $5.0M | 40.3% |
| 2 | $25.00 | 296,000 | $7.4M | 59.7% |
| Total | $25.00 avg | 496,000 | $12.4M | 100% |
| Filing → |
| TORC | BUY | 2018-01-30 | $8.0M | — | Filing → |
| GKOS | SELL | 2017-09-05 | $22.5M | — | Filing → |
| GKOS | SELL | 2017-08-17 | $16.0M | — | Filing → |